| Kleanthis G. Xanthopoulos, Ph.D. President and Chief Executive Officer  |
Garry E. Menzel, Ph.D. Chief Operating Officer and Executive Vice President of Finance  |
| Neil W. Gibson, Ph.D. Chief Scientific Officer  |
Mary Glanville Senior Vice President of Human Capital  |
| Hubert C. Chen, M.D. Vice President of Translational Medicine  |
 |
microRNA Insights
Kleanthis G. Xanthopoulos, Ph. D.
President & Chief Executive Officer
"The Impact of microRNA Medicines"
Garry E. Menzel, Ph. D.
Chief Operating Officer & Executive Vice President of Finance
"Business Strategy and Focus"
Neil W. Gibson, Ph. D.
Chief Scientific Officer
"microRNAs as a New Class of Drug Targets"
Mary Glanville
Senior Vice President of Human Capital
"Culture and Core Values"